Technology M&A Advisory

M&A Advisory

Lazard

Full Credential Description

Dendreon. United States. Announced Date 16/11/2006. Closed Date 21/11/2006. Deal value: $45m. Registered direct offering of common stock. Industry: Dendreon is a biotechnology company focused on developing and commercializing cancer immunotherapy treatments.

Back to Search Contact Business